RYFIONQ

Serial Number 79249966
Registration 5859535
700

Registration Progress

Application Filed
Dec 12, 2018
Under Examination
Approved for Publication
Jul 2, 2019
Published for Opposition
Jul 2, 2019
Registered
Sep 17, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-09-17)
Due: Sep 17, 2025 51 days

Trademark Image

RYFIONQ

Basic Information

Serial Number
79249966
Registration Number
5859535
Filing Date
December 12, 2018
Registration Date
September 17, 2019
Published for Opposition
July 2, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 17, 2019
Registration
Registered
Classes
005

Rights Holder

Isofol Medical AB (publ)

64
Address
Biotech Center
Arvid Wallgrens Backe 20, 5 tr SE-413 46 Göteborg
SE

Ownership History

Isofol Medical AB (publ)

Original Applicant
64
SE

Isofol Medical AB (publ)

Owner at Publication
64
SE

Isofol Medical AB (publ)

Original Registrant
64
SE

Legal Representation

Attorney
Josh A. Partington

USPTO Deadlines

Next Deadline
51 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-09-17)
Due Date
September 17, 2025
Grace Period Ends
March 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Sep 17, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Jan 31, 2020 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 15, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 15, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 17, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 17, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 2, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 2, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jun 12, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 12, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jun 12, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 24, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 22, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 22, 2019 ALIE A ASSIGNED TO LIE Loading...
May 16, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 5, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 21, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 21, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 13, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 12, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 11, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 29, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 25, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 24, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations used for cancer treatment of human patients provided by medical professionals at health care facilities

Classification

International Classes
005